Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key ...

StockNews.com lowered shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) from a strong-buy rating to a buy rating ...

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 2,030,000 shares, a ...

On-demand video webcast now available here TAMPA, FL / ACCESS Newswire / February 19, 2025 / TuHURA Biosciences, Inc. (NASDAQ:HURA) ...

Harmony Sciences shares plunged Wednesday after the FDA rejected its bread-and-butter drug as a treatment for a daytime sleepiness condition.

Harmony Biosciences (HRMY) announced that it received a refusal to file letter from the FDA for pitolisant for the treatment of excessive ...

Nakatomi is targeting a third trip to the Breeders’ Cup Sprint, having run third at odds of 26-1 behind two-time champion ...

A Senate Commerce Committee report released last week labeled more than $3 million in federal grants to Harvard researchers ...

Harmony Biosciences is facing more of a nightmare than sweet dreams on the road to securing a new use for its excessive ...

It is a lie from the pit of hell. There is no truth in the story. I am doing my work as the CPS, the Speaker is in her office ...

This page features the latest news about the Cellectar Biosciences stock. Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy for Solid Tumors, Releases Promising Preclinical Data ...

Speaker of the Anambra State House of Assembly, Somtochukwu Nkem Udeze, has expressed shock over the report that suspects ...